PMC2703251_01
DLCO (%), VC max (%) and FEV1 (%) in a male subject with acute amiodarone pneumonitis before and after cessation of therapy (August 12, 2004). . Values in % of normal value.
GMS-03-03-g-001.jpg
PMC2703251_01_GMS-03-03-g-001.jpg
F1
Routine lung function on July 21, 2004 showed no abnormalities (Figure 1 (Fig. 1)). DLCO with no relevant changes in Vital Capacity and FEV1 (Figure 1 (Fig. 1)). During standardized six minute walking test losses in PaO2 (minimal value 08/18/04: 48 mmHg) could be recorded three weeks running.  As can be seen in Figure 1 (Fig. 1) complete remission of DLCO to normal values was achieved and maintained through follow-up inspections.